Rice Hall James & Associates’s Encompass Health EHC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $3.9M | Buy |
40,338
+1,940
| +5% | +$199K | 0.22% | 103 |
|
|
2025
Q4 | $4.08M | Sell |
38,398
-2,545
| -6% | -$295K | 0.22% | 104 |
|
|
2025
Q3 | $5.2M | Sell |
40,943
-313
| -0.8% | -$37.3K | 0.28% | 82 |
|
|
2025
Q2 | $5.06M | Sell |
41,256
-56
| -0.1% | -$6.4K | 0.27% | 81 |
|
|
2025
Q1 | $4.18M | Sell |
41,312
-4,853
| -11% | -$474K | 0.25% | 87 |
|
|
2024
Q4 | $4.26M | Sell |
46,165
-452
| -1% | -$44.4K | 0.23% | 93 |
|
|
2024
Q3 | $4.51M | Sell |
46,617
-7,521
| -14% | -$676K | 0.24% | 94 |
|
|
2024
Q2 | $4.64M | Sell |
54,138
-973
| -2% | -$81.7K | 0.28% | 79 |
|
|
2024
Q1 | $4.55M | Buy |
55,111
+7,225
| +15% | +$529K | 0.26% | 86 |
|
|
2023
Q4 | $3.19M | Sell |
47,886
-920
| -2% | -$59.6K | 0.19% | 120 |
|
|
2023
Q3 | $3.28M | Buy |
48,806
+6,660
| +16% | +$458K | 0.21% | 113 |
|
|
2023
Q2 | $2.85M | Sell |
42,146
-237
| -0.6% | -$14.9K | 0.16% | 142 |
|
|
2023
Q1 | $2.29M | Sell |
42,383
-691
| -2% | -$40.2K | 0.13% | 172 |
|
|
2022
Q4 | $2.58M | Sell |
43,074
-1,195
| -3% | -$65K | 0.15% | 161 |
|
|
2022
Q3 | $2M | Sell |
44,269
-11,905
| -21% | -$596K | 0.12% | 185 |
|
|
2022
Q2 | $2.5M | Sell |
56,174
-548
| -1% | -$28.1K | 0.12% | 171 |
|
|
2022
Q1 | $3.21M | Sell |
56,722
-385
| -0.7% | -$20.1K | 0.13% | 158 |
|
|
2021
Q4 | $2.96M | Sell |
57,107
-447
| -0.8% | -$23.1K | 0.11% | 177 |
|
|
2021
Q3 | $3.44M | Sell |
57,554
-668
| -1% | -$42K | 0.13% | 123 |
|
|
2021
Q2 | $3.61M | Sell |
58,222
-18,633
| -24% | -$1.24M | 0.13% | 122 |
|
|
2021
Q1 | $5.01M | Sell |
76,855
-1,054
| -1% | -$68.7K | 0.16% | 112 |
|
|
2020
Q4 | $5.13M | Sell |
77,909
-27,842
| -26% | -$1.64M | 0.18% | 101 |
|
|
2020
Q3 | $5.47M | Sell |
105,751
-61,441
| -37% | -$3.15M | 0.22% | 92 |
|
|
2020
Q2 | $8.24M | Sell |
167,192
-10,564
| -6% | -$570K | 0.35% | 77 |
|
|
2020
Q1 | $9.05M | Sell |
177,756
-136,928
| -44% | -$7.89M | 0.51% | 59 |
|
|
2019
Q4 | $17.3M | Sell |
314,684
-4,686
| -1% | -$254K | 0.59% | 66 |
|
|
2019
Q3 | $16.1M | Sell |
319,370
-19,751
| -6% | -$992K | 0.57% | 65 |
|
|
2019
Q2 | $17.1M | Sell |
339,121
-28,001
| -8% | -$1.36M | 0.57% | 64 |
|
|
2019
Q1 | $17.1M | Buy |
367,122
+88,201
| +32% | +$4.47M | 0.55% | 64 |
|
|
2018
Q4 | $13.7M | Sell |
278,921
-45,258
| -14% | -$2.57M | 0.5% | 77 |
|
|
2018
Q3 | $20.1M | Sell |
324,179
-107,049
| -25% | -$6.51M | 0.72% | 49 |
|
|
2018
Q2 | $23.2M | Sell |
431,228
-23,077
| -5% | -$1.15M | 0.84% | 30 |
|
|
2018
Q1 | $20.7M | Sell |
454,305
-11,745
| -3% | -$503K | 0.81% | 40 |
|
|
2017
Q4 | $18.3M | Sell |
466,050
-29,530
| -6% | -$1.12M | 0.72% | 54 |
|
|
2017
Q3 | $18.3M | Sell |
495,580
-24,349
| -5% | -$868K | 0.81% | 51 |
|
|
2017
Q2 | $20M | Buy |
519,929
+953
| +0.2% | +$34.9K | 0.87% | 46 |
|
|
2017
Q1 | $17.7M | Sell |
518,976
-14,177
| -3% | -$466K | 0.86% | 50 |
|
|
2016
Q4 | $17.5M | Sell |
533,153
-10,703
| -2% | -$347K | 0.88% | 44 |
|
|
2016
Q3 | $17.6M | Sell |
543,856
-2,082
| -0.4% | -$67.5K | 0.92% | 48 |
|
|
2016
Q2 | $16.9M | Sell |
545,938
-5,986
| -1% | -$187K | 0.97% | 31 |
|
|
2016
Q1 | $16.5M | Sell |
551,924
-1,563
| -0.3% | -$43.2K | 0.95% | 38 |
|
|
2015
Q4 | $15.3M | Sell |
553,487
-7,515
| -1% | -$214K | 0.88% | 47 |
|
|
2015
Q3 | $17.1M | Buy |
561,002
+3,047
| +0.5% | +$106K | 1.11% | 30 |
|
|
2015
Q2 | $20.4M | Sell |
557,955
-377
| -0.1% | -$13.4K | 1.18% | 20 |
|
|
2015
Q1 | $19.7M | Sell |
558,332
-9,999
| -2% | -$342K | 1.14% | 18 |
|
|
2014
Q4 | $17.4M | Sell |
568,331
-13,646
| -2% | -$425K | 1.06% | 29 |
|
|
2014
Q3 | $17.1M | Sell |
581,977
-4,553
| -0.8% | -$139K | 1.19% | 23 |
|
|
2014
Q2 | $16.7M | Buy |
586,530
+78,189
| +15% | +$2.18M | 1.13% | 33 |
|
|
2014
Q1 | $14.5M | Sell |
508,341
-22,909
| -4% | -$596K | 1.07% | 31 |
|
|
2013
Q4 | $14.1M | Sell |
531,250
-141,659
| -21% | -$3.94M | 1.02% | 42 |
|
|
2013
Q3 | $18.5M | Sell |
672,909
-67,680
| -9% | -$1.74M | 1.77% | 3 |
|
|
2013
Q2 | $17M | Buy |
+740,589
| New | +$16.7M | 1.67% | 6 |
|
Other funds holding EHC
VPM
VCM
Rice Hall James & Associates's EHC Position: Q1 2026 in Review
Rice Hall James & Associates increased its Encompass Health (EHC) stake by 5.1% in Q1 2026, buying an estimated $199K and bringing the position to 40,338 shares worth $3.9M. The position accounts for 0.22% of the portfolio, ranked #103.
Rice Hall James & Associates first reported a position in EHC in Q2 2013 and has held it in 52 quarters since. The position peaked at $23.2M in Q2 2018. 578 funds tracked by Wall St. Rank hold EHC as of Q1 2026.
- Rice Hall James & Associates held 40,338 shares of Encompass Health worth $3.9M as of Q1 2026.
- Rice Hall James & Associates bought 1,940 Encompass Health shares in Q1 2026, an estimated $199K.
- Encompass Health made up 0.22% of Rice Hall James & Associates's portfolio in Q1 2026, its #103 holding.
- Rice Hall James & Associates first reported a position in Encompass Health in Q2 2013 and has held it in 52 quarters since.
- Rice Hall James & Associates's Encompass Health position peaked at $23.2M in Q2 2018.
- 578 funds tracked by Wall St. Rank held Encompass Health as of Q1 2026.
Based on Rice Hall James & Associates's 13F filing for Q1 2026, filed 15 May 2026.